Issues and Reviews in Teratology: Volume 2
Editat de Harold Kalteren Limba Engleză Paperback – 22 iun 2012
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (3) | 354.92 lei 6-8 săpt. | |
| Springer Us – 27 sep 2011 | 354.92 lei 6-8 săpt. | |
| Springer Us – 5 noi 2012 | 358.05 lei 6-8 săpt. | |
| Springer Us – 22 iun 2012 | 366.00 lei 6-8 săpt. | |
| Hardback (1) | 625.60 lei 6-8 săpt. | |
| Springer – 31 iul 1993 | 625.60 lei 6-8 săpt. |
Preț: 366.00 lei
Preț vechi: 385.26 lei
-5% Nou
Puncte Express: 549
Preț estimativ în valută:
64.79€ • 75.34$ • 56.61£
64.79€ • 75.34$ • 56.61£
Carte tipărită la comandă
Livrare economică 22 ianuarie-05 februarie 26
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781461573166
ISBN-10: 1461573165
Pagini: 536
Ilustrații: XVI, 516 p. 35 illus.
Dimensiuni: 152 x 229 x 28 mm
Greutate: 0.71 kg
Ediția:Softcover reprint of the original 1st ed. 1984
Editura: Springer Us
Colecția Springer
Locul publicării:New York, NY, United States
ISBN-10: 1461573165
Pagini: 536
Ilustrații: XVI, 516 p. 35 illus.
Dimensiuni: 152 x 229 x 28 mm
Greutate: 0.71 kg
Ediția:Softcover reprint of the original 1st ed. 1984
Editura: Springer Us
Colecția Springer
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
1 Birth Defects Monitoring Systems: Accomplishments and Goals.- 1. Introduction.- 2. Further Reasons for Registering Malformations.- 3. Fundamentals of Malformation Registration.- 4. What Should Be Monitored?.- 5. The Problem of Ascertainment.- 6. Size of Population Monitored.- 7. Properties of Monitoring Systems and Ascertainment Rates.- 8. Detection of Changes in Prevalence.- 9. Limitations and Benefits of Monitoring Systems.- References.- 2 What Is a Teratogen? Epidemiological Criteria.- 1. Introduction.- 2. Definition of a Teratogen.- 3. Criteria of Judgment in Epidemiology.- 4. Dealing with Doubt.- 5. Raising the Alert.- 6. Conclusion.- References.- 3 Congenital Hydrocephalus in Mice and Man.- 1. Introduction.- 2. Teratology.- 3. Discussion.- References.- 4 Congenital Defects of Domestic and Feral Animals.- 1. Introduction.- 2. Definitions.- 3. Nature and Effect.- 4. Frequency.- 5. Causes.- 6. Specific Defects.- 7. Conclusions.- References.- 5 Transplacental Exposure to Diethylstilbestrol.- 1. Introduction.- 2. Clinical Research.- 3. Animal Research.- 4. Mechanism of Transplacental Carcinogenesis.- References.- 6 Hormones, Growth Factors, and Their Receptors in Normal and Abnormal Prenatal Development.- 1. Introduction.- 2. Steroids.- 3. Growth Hormones and Factors.- 4. Dioxins and Their Receptors in Teratology.- 5. Benzodiazepine and Opiate Receptors.- 6. Summary and Conclusions.- References.- 7 Vertebrate Limb Morphogenesis: A Review of Normal Development in a Model Experimental System with Applications toward Understanding Abnormal Limb Formation.- 1. Introduction.- 2. The Apical Ectodermal Ridge.- 3. Mesoderm and Limb Patterns.- 4. Extracellular Matrix.- 5. Cell Death.- 6. Limb Mutants.- 7. Dysmorphogenesis.- 8. Summary.- References.- 8 Teratogenicity of Experimental and Occupational Exposure to Industrial Chemicals.- 1. Introduction.- 2. Alcohols (Ethanol).- 3. Aldehydes.- 4. Heavy Metals.- 5. Halogenated Hydrocarbons (Chlorinated Solvents).- 6. Ketones.- 7. Organic Solvents.- 8. Plastics and Related Chemicals.- 9. Chlorobenzenes and Carbon Monoxide.- 10. Discussion and Conclusions.- References.- 9 Critical Assessment of Genetic Effects of Ionizing Radiation on Pre- and Postnatal Development.- 1. Introduction.- 2. Prologue.- 3. The Human Experience.- 4. Permissible Exposures.- 5. Future Directions.- 6. Glossary.- References.- 10 Adverse Effects in Humans and Animals of Prenatal Exposure to Selected Therapeutic Drugs and Estimation of Embryo-Fetal Sensitivity of Animals for Human Risk Assessment: A Review.- 1. Introduction.- 2. Aspirin and Salicylates.- 3. Progestational Agents.- 4. Anticonvulsant Drugs.- 5. Phenothiazines.- 6. Meprobamate.- 7. Pregnancy Toxemia and Reserpine.- 8. Thalidomide.- 9. Isoniazid.- 10. Tetracyclines.- 11. Aminopterin.- 12. Methotrexate.- 13. Fetal Sensitivity in Animals Relative to Humans: Conclusions.- 14. Summary.- References.